Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche's Actemra successful in arthritis study
Reuters
Friday, November 20, 2009 - 8:26am
tags:
arthritis, Actemra, Roche
Pfizer Is Best Positioned Big Pharma in China - Goldman
Seeking Alpha
Friday, November 20, 2009 - 7:23am
tags:
China, Pfizer, Big Pharma
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
Seeking Alpha
Friday, November 20, 2009 - 6:51am
tags:
FDA, Merck, Santarus, Zegrid
Genzyme: This Stock Is a Train Wreck
Motley Fool
Friday, November 20, 2009 - 6:35am
tags:
Genzyme
U.S. House Votes to Avert Cuts in Medicare Payments to Doctors
Bloomberg
Friday, November 20, 2009 - 6:34am
tags:
Medicare, healthcare reform
Pfizer Dodges a Bullet
Motley Fool
Friday, November 20, 2009 - 6:32am
tags:
Pfizer, Wyeth, Prevnar, vaccines
NeurogesX: Next Stop, U.S. Market
Seeking Alpha
Thursday, November 19, 2009 - 4:19pm
tags:
Astellas, NeurogesX, Qutenza
Ligand Pharmaceuticals receives $2 million from research partnership with Merck
Yahoo/AP
Thursday, November 19, 2009 - 4:19pm
tags:
partnerships, Merck, Ligand
Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash
BNET Pharma
Thursday, November 19, 2009 - 3:39pm
tags:
Merck, Schering Plough
Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows
Seeking Alpha
Thursday, November 19, 2009 - 3:35pm
tags:
pipelines, generics, patents, AstraZeneca, Bristol-Myers Squibb, Pfizer, Eli Lilly
FDA panel backs stronger benefit claims and safety profile for inhaler drug Spiriva
Yahoo/AP
Thursday, November 19, 2009 - 3:34pm
tags:
inhaler, Spiriva, FDA, Boehringer Ingelheim
Congress wants GAO to probe drug prices
Fierce Pharma
Thursday, November 19, 2009 - 10:40am
tags:
GAO, drug prices, congress
Plavix Label Change: Good For Effient Now, Bad For Brands in the Long Run?
InVivo
Thursday, November 19, 2009 - 10:33am
tags:
blood thinners, Plavix, Effient, Eli Lilly, Bristol-Myers Squibb, Sanofi, Daiichi Sankyo
ImmuPharma CEO slams stock plunge after drug trial
Reuters
Thursday, November 19, 2009 - 10:30am
tags:
drug trials, ImmuPharma, lupuzor
Poniard Pharmaceuticals' Gamble Doesn't Pay Off
Seeking Alpha
Thursday, November 19, 2009 - 10:29am
tags:
Poniard, picoplatin
U.S. Sees Low Demand for BioCryst Flu Drug
TheStreet.com
Thursday, November 19, 2009 - 10:28am
tags:
Flu, Biocryst, peramivir
Genzyme Drops Kidney-Drug Plans Amid Pileup of Bad News
WSJ Online
Thursday, November 19, 2009 - 10:23am
tags:
Pompe disease, Genzyme
Should You Buy It? Alkermes
TheStreet.com
Thursday, November 19, 2009 - 9:58am
tags:
Alkermes
Flu Shot Made From Caterpillars May Win Pivotal U.S. Backing
Bloomberg
Thursday, November 19, 2009 - 9:56am
tags:
FluBlok, Flu, vaccines, Protein Biosciences
J&J vs. 10-Year T-Bonds: The Power of Rising Dividends
Seeking Alpha
Thursday, November 19, 2009 - 9:53am
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.